R J Soiffer
Overview
Explore the profile of R J Soiffer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
1584
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Motta A, Zhan Q, Larson A, Lerman M, Woo S, Soiffer R, et al.
Oral Dis
. 2017 Dec;
24(4):580-590.
PMID: 29197137
Objective: To characterize the immunohistopathological features of oral chronic graft-versus-host disease (cGVHD), and the impact of topical immunomodulatory therapy on the infiltrating cells. Material And Methods: Paired oral cGVHD biopsies...
2.
El-Jawahri A, Kim H, Steensma D, Cronin A, Stone R, Watts C, et al.
Bone Marrow Transplant
. 2016 Mar;
51(8):1121-6.
PMID: 26999469
The factors that influence utilization of reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (HCT) among medically fit older patients with advanced myelodysplastic syndromes (MDS) are largely unknown. The MDS...
3.
Garfall A, Kim H, Sun L, Ho V, Armand P, Koreth J, et al.
Bone Marrow Transplant
. 2013 Jan;
48(7):1000-2.
PMID: 23318536
No abstract available.
4.
Brown J, Kim H, Armand P, Cutler C, Fisher D, Ho V, et al.
Leukemia
. 2012 Sep;
27(2):362-9.
PMID: 22955330
Chronic lymphocytic leukemia (CLL) remains incurable with chemoimmunotherapy, and allogeneic hematopoietic stem cell transplantation (HSCT) offers the potential for cure. We assessed the outcomes of 108 CLL patients undergoing first...
5.
Armand P, Sainvil M, Kim H, Rhodes J, Cutler C, Ho V, et al.
Bone Marrow Transplant
. 2012 May;
48(1):146-7.
PMID: 22609885
No abstract available.
6.
Abou-Nassar K, Stevenson K, Antin J, McDermott K, Ho V, Cutler C, et al.
Bone Marrow Transplant
. 2011 Jan;
46(12):1503-9.
PMID: 21258420
Reduced-intensity conditioning (RIC) hematopoietic SCT (HSCT) is a potentially curative therapeutic option for patients with advanced follicular lymphoma (FL), but disease relapse remains the most common cause of failure. Radioimmunoconjugates...
7.
Jacobsen E, Kim H, Ho V, Cutler C, Koreth J, Fisher D, et al.
Ann Oncol
. 2011 Jan;
22(7):1608-1613.
PMID: 21252059
Background: The prognosis for patients with most forms of T-cell lymphoma is poor. Allogeneic hematopoietic stem-cell transplantation (HSCT) may improve the outcome. Patients And Methods: This study examines the outcome...
8.
Armand P, Kim H, Mayer E, Cutler C, Ho V, Koreth J, et al.
Bone Marrow Transplant
. 2010 Feb;
45(11):1611-7.
PMID: 20154738
Women with breast cancer who receive adjuvant therapy are at risk for developing therapy-related myelodysplastic syndrome (MDS) or AML (tMDS/AML). Patients with tMDS/AML are often referred for consideration of allogeneic...
9.
Armand P, Deeg H, Kim H, Lee H, Armistead P, de Lima M, et al.
Bone Marrow Transplant
. 2009 Sep;
45(5):877-85.
PMID: 19784076
Cytogenetics is an important prognostic factor for patients with myelodysplastic syndromes (MDS). However, existing cytogenetics grouping schemes are based on patients treated with supportive care, and may not be optimal...
10.
Haspel R, Kao G, Yeap B, Cutler C, Soiffer R, Alyea E, et al.
Bone Marrow Transplant
. 2007 Nov;
41(6):523-9.
PMID: 18037942
Double cord blood transplantation (DCBT) may overcome the slow hematopoietic recovery and engraftment failure associated with infusion of a single cord blood unit. In DCBT, only one unit typically contributes...